NCT00609531View on ClinicalTrials.gov

Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Autism Spectrum Disorders
Interventions
DRUG

Citalopram

Pill, 5-20mg once a day for twelve weeks

DRUG

Placebo

Placebo pill once a day for twelve weeks

Trial Locations (1)

27759

UNC-Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT00609531 - Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders | Biotech Hunter | Biotech Hunter